Riyaz Bashir, MD, FACC, Director of Vascular and Endovascular Medicine at Temple University Hospital and Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective for a TCTMD.com article about an Annals of Internal Medicine paper which examines the case of certain inferior vena cava (IVC) filters and includes new information uncovered during litigation which the authors believe should have been made available to the U.S. Food and Drug Administration (FDA) and the public.